Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (CTRI/2026/09/117106) titled 'Evaluation and Efficacy of human plasma as eyedrop in Ocular Surface Inflammatory Diseases' on Sept. 7.
Study Type: Interventional
Study Design:
Single Arm Study Method of generating randomization sequence:Not Applicable Method of allocation concealment:Not Applicable Blinding and masking:Not Applicable
Primary Sponsor: L V Prasad Eye Institite
Condition:
Health Condition 1: H188- Other specified disorders of cornea
Intervention:
Intervention1: Allogenic Plasma eye drops: long-term treatment with allogenic plasma eye drops (20% v/v) prepared from healthy screened donors may provides more standardiz...